(b)(4).Exemption number: e2016031.(b)(4).The following additional information was also provided: ¿could you clarify if the stent was deployed in the patient and then retrieved? or if the stent was partially deployed when removed from the patient's body? the stent did not deploy.¿ 1 x evo-25-30-8-c was returned to cirl for evaluation.On evaluation of the returned device, it was noted that the stent was partially exposed from sheath on return.However, as the following information was provided: ¿could you clarify if the stent was deployed in the patient and then retrieved? or if the stent was partially deployed when removed from the patient's body? the stent did not deploy¿, it is assumed that the stent became exposed when device was removed from the patient due to pressure release.The red shuttle deployment marker was towards the back half of the handle on return.The lockwire was still in place.It was not possible to deploy or retract the stent as actuation of the device was not possible pulling the trigger.The handle was dismantled during lab evaluation to show that the flexor had broken at the shuttle cap.The stent was manually deployed and was noted to be fine.The customer complaint was confirmed as the flexor was broken at the shuttle cap.As usage condition cannot be replicated within the laboratory setting, a definitive root cause cannot be conclusively determined.A possible cause for the issue occurring may be due to delamination of the ptfe liner of the outer sheath there were no other discrepancies in the manufacturing records that could have contributed to this complaint issue.The instructions for use, which accompanies this device instructs the user to "visually inspect with particular attention to kinks, bends and breaks.If an abnormality is detected that would prohibit proper working condition, do not use".From the information provided, there have been no adverse effects to the patient as a result of this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
|